Researchers Discover New Breast Cancer Culprit
When scientists identify concentrations of regulatory T cells (immune-system cells) in breast cancer tumors, it usually signifies an unfavorable prognosis. Now researchers have uncovered why.
More than PMS ...
Premenstrual mood shifts are associated with depressive symptoms and bipolar disorder, according to a new study.
Resveratrol and Rapamycin: A Power Couple
Resveratrol, a compound found in red wine, may have a tumor-suppressing effect on breast cancer cells when combined with rapamycin, an immunosuppressant drug.
Fooled by Folic Acid?
According to a new study working with rat animal models, female offspring of rats who took folic acid supplements before conception, during pregnancy and while breast-feeding have twice the rate of breast cancer.
Pressure to Get the Lead Out
Even the smallest quantities of lead can affect the blood pressure of a pregnant woman, according to a recent study from researchers at the Johns Hopkins Hospital.
Breast Cancer Surgery May Become Less Invasive
A new study finds that removing underarm lymph nodes in women with early breast cancer (and who also undergo a lumpectomy) may not be necessary, thus saving them considerable pain and complications.
Female Facebook Users Can Develop Eating Disorders
A new study from the University of Haifa finds girls who spend more time on Facebook, the social networking Web site, are more likely to develop eating disorders.
Aggressive Form of Breast Cancer Linked to Gene Mutation
A new study from Tufts University School of Medicine finds why individuals who inherit a particular family of mutations have a higher risk of developing a very aggressive form of breast cancer.
You'll Want to Return This Gift from Mother
New research from the University of Oxford, England, shows a mother's stroke can help predict her daughter's heart attack.
Down but Not Out
Breast cancer survivors may be prone to hip fractures once they hit middle age, according to a study from Northwestern University Feinberg School of Medicine.